The Identification of Gut Neuroendocrine Tumor Disease by Multiple Synchronous Transcript Analysis in Blood

Abstract excerpt

Gastroenteropancreatic (GEP) neuroendocrine neoplasms (NENs) are increasing in both incidence and prevalence. A delay in correct diagnosis is common for these lesions. This reflects the absence of specific blood biomarkers to detect NENs. Measurement of the neuroendocrine secretory peptide Chromogranin A (CgA) is used, but is a single value, is non-specific and assay data are highly variable. To facilitate tumor...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Gestational Trophoblastic Disease Studies
• Share to Lung Cancer Research Studies
• Share to Neuroendocrine Tumor Research Advances